The 8 analysts offering 12-month price forecasts for Collegium Pharmaceutical Inc have a median target of 27.00, with a high estimate of 36.00 and a low estimate of 8.00. The median estimate represents a +54.07% increase from the last price of 17.52.
The current consensus among 8 polled investment analysts is to Buy stock in Collegium Pharmaceutical Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.04
Reporting Date Mar 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.